tradingkey.logo

Canada's DRI Healthcare annual income hits record, raises distribution

ReutersMar 4, 2026 12:22 AM


Overview

  • Canada's pharma royalty firm reported a total income of $61.7 mln in Q4 and a record of $198.6 mln for the year

  • Adjusted EBITDA margin for Q4 was 91%

  • Subsequent to quarter-end, the company announced a quarterly distribution increase to $0.11 per unit for 2026


Outlook

  • DRI Healthcare expects 2026 adjusted EBITDA between $157 mln and $162 mln

  • Company aims for $800 mln to $1 bln capital deployment from 2026 to 2030

  • DRI Healthcare plans low teens CAGR for adjusted EBITDA from 2026 to 2030


Result Drivers

  • INTERNALIZATION BENEFITS - DRI Healthcare completed the internalization of its investment management function, with benefits pacing ahead of schedule, contributing to a 91% adjusted EBITDA margin

  • CAPITAL DEPLOYMENT - Achieved five-year deployment target of $1.25 bln, including potential near-term milestone payments


Company press release: ID:nCNWB4vHya


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Total Income

$61.69 mln

Q4 Adjusted Cash Earnings per Unit

$0.77

Q4 Net Income

$8.77 mln

Q4 Adjusted EBITDA

$46.24 mln

Q4 Adjusted EBITDA Margin

91.00%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Dri Healthcare Trust is C$20.72, about 26.7% above its March 3 closing price of C$16.35


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI